Home/Filings/4/0001209191-23-029095
4//SEC Filing

Jovan-Embiricos Morana 4

Accession 0001209191-23-029095

CIK 0001754068other

Filed

May 11, 8:00 PM ET

Accepted

May 12, 5:00 PM ET

Size

10.9 KB

Accession

0001209191-23-029095

Insider Transaction Report

Form 4
Period: 2023-05-11
Transactions
  • Award

    Common Stock

    2023-05-11+35,00065,197 total
Holdings
  • Common Stock

    (indirect: By LLC)
    16,674,766
  • Common Stock

    (indirect: By LLC)
    668,072
  • Common Stock

    (indirect: Shares held by F2 MG Limited ()
    2,059,884
  • Common Stock

    (indirect: By LLC)
    4,193,874
Footnotes (5)
  • [F1]The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the AlloVir, Inc. 2020 Stock Option and Grant Plan (the "Plan"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The shares shall vest upon the earlier to occur of (i) May 11, 2024 and (ii) the next annual meeting of the Issuer's stockholders.
  • [F2]Shares held by ElevateBio. The Reporting Person is a director of ElevateBio, and may be deemed to have shared voting and investment power of the shares held by ElevateBio. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F3]Shares held by F2-TPO. Globeways Holdings II Limited is the appointed manager of F2-TPO and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2-TPO. The Reporting Person is the founding director of Globeways Holdings II Limited. Morana Jovan-Embiricos has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F4]Shares held by F2 MG. Globeways Holdings Limited is the appointed manager of F2 MG and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MG. The Reporting Person is the founding director of Globeways Holdings Limited. Morana Jovan-Embiricos has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings Limited. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F5]Shares held by F2 2020. Globeways Holdings II Limited is the appointed manager of F2 2020 and has sole power to vote upon the acquisition, holding and disposal of all shares held by F2 2020. The Reporting Person is the founding director of Globeways Holdings II Limited. Morana Jovan-Embiricos has the sole power to vote upon the acquisition, holding and disposal of all shares and warrants held by Globeways Holdings II Limited. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Issuer

Allovir, Inc.

CIK 0001754068

Entity typeother

Related Parties

1
  • filerCIK 0001575745

Filing Metadata

Form type
4
Filed
May 11, 8:00 PM ET
Accepted
May 12, 5:00 PM ET
Size
10.9 KB